251 related articles for article (PubMed ID: 12506161)
1. Something old, something few, something subjective, something déjà vu.
Horning SJ
J Clin Oncol; 2003 Jan; 21(1):1-2. PubMed ID: 12506161
[No Abstract] [Full Text] [Related]
2. Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.
Peterson BA; Petroni GR; Frizzera G; Barcos M; Bloomfield CD; Nissen NI; Hurd DD; Henderson ES; Sartiano GP; Johnson JL; Holland JF; Gottlieb AJ
J Clin Oncol; 2003 Jan; 21(1):5-15. PubMed ID: 12506163
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
4. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
5. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
6. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
8. Management of patients with low-grade follicular lymphoma.
Cabanillas FF
Am J Clin Oncol; 1989 Feb; 12(1):81-7. PubMed ID: 2463754
[No Abstract] [Full Text] [Related]
9. Ileal polyposis caused by follicular lymphoma.
Matsuura M; Nakase H; Mochizuki N
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):e30. PubMed ID: 17625984
[No Abstract] [Full Text] [Related]
10. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
Messori A; Fadda V; Maratea D; Trippoli S
Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
[No Abstract] [Full Text] [Related]
12. [Primary cutaneous follicle centre lymphoma: report of a case].
Rong YF; He LM; Zhang YS; Feng YZ
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
[No Abstract] [Full Text] [Related]
13. Does monocyte count have prognostic significance in cancer?
Tadmor T
Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
[No Abstract] [Full Text] [Related]
14. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
[No Abstract] [Full Text] [Related]
15. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
16. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Sagar TG; Chandra A; Raman SG
Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
[No Abstract] [Full Text] [Related]
17. Subcutaneous rituximab and chemotherapy achieves similar overall response rates to intravenous rituximab in first-line follicular lymphoma: efficacy and safety results of the phase III SABRINA study.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):6-7. PubMed ID: 25768992
[No Abstract] [Full Text] [Related]
18. Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.
Kose F; Abali H; Sezer A; Mertsoylu H; Disel U; Ozyilkan O
Leuk Lymphoma; 2009 Feb; 50(2):282-3. PubMed ID: 19197737
[No Abstract] [Full Text] [Related]
19. Angiocentric lymphoma--a case report.
Gupta P; Bijlani L; Dawar R
Indian J Pathol Microbiol; 1991 Oct; 34(4):293-5. PubMed ID: 1726321
[No Abstract] [Full Text] [Related]
20. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy].
Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
